Indeed, in RA patients, treatment with TNF-α inhibitors was associated with a decrease in the incidence of CVD [145], an increase in HDL-c levels and an improvement of the quality of phospholipids-HDL. This evidence concerns the gene TNF and rheumatoid arthritis.